A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 16959577.
- Also identified by PMC identifier 3290523.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rapid and reversible methods for perturbing the function of specific proteins are desirable tools for probing complex biological systems. We have developed a general technique to regulate the stability of specific proteins in mammalian cells using cell-permeable, synthetic molecules. We engineered mutants of the human FKBP12 protein that are rapidly and constitutively degraded when expressed in mammalian cells, and this instability is conferred to other proteins fused to these destabilizing domains. Addition of a synthetic ligand that binds to the destabilizing domains shields them from degradation, allowing fused proteins to perform their cellular functions. Genetic fusion of the destabilizing domain to a gene of interest ensures specificity, and the attendant small-molecule control confers speed, reversibility, and dose-dependence to this method. This general strategy for regulating protein stability should enable conditional perturbation of specific proteins with unprecedented control in a variety of experimental settings.
Medical subject headings
- Gene Expression Regulation
- Morpholines
- Proteasome Endopeptidase Complex
- Recombinant Fusion Proteins
- Tacrolimus Binding Protein 1A
- Tacrolimus Binding Proteins